SECUKINUMAB

119249 reported adverse events

Drug classes: Interleukin-17A Antagonist [EPC]

These side effects are most commonly reported by patients taking SECUKINUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 21234
1 PSORIASIS 17181
2 PAIN 10849
3 ARTHRALGIA 9577
4 FATIGUE 6130
5 MALAISE 6009
6 PRURITUS 5826
7 PSORIATIC ARTHROPATHY 5379
8 RASH 4931
9 DIARRHOEA 4826
See all common reactions for SECUKINUMAB

SECUKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND PSORIASIS 247 0.5995
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 88 0.5057
2 LUPUS VULGARIS 56 0.4828
3 RED BLOOD CELL SEDIMENTATION RATE 105 0.4217
4 TONSILLAR ULCER 41 0.3361
5 MACULE 596 0.2852
6 SWOLLEN JOINT COUNT INCREASED 244 0.2831
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 89 0.2816
8 NAIL PSORIASIS 114 0.2734
9 SERONEGATIVE ARTHRITIS 156 0.2708
See all enriched reactions for SECUKINUMAB